首页|低病毒载量HBeAg阴性慢性HBV感染者不确定期临床特征分析

低病毒载量HBeAg阴性慢性HBV感染者不确定期临床特征分析

扫码查看
目的 分析低病毒载量乙型肝炎e抗原(HBeAg)阴性慢性乙型肝炎病毒(HBV)感染者的不确定期临床特征.方法 回顾性收集139例2013年9月至2021年7月于延安大学附属医院感染病科就诊的丙氨酸转氨酶(ALT)持续正常低病毒载量HBeAg阴性慢性HBV感染者,根据患者基线乙型肝炎表面抗原(HBsAg)水平分为低HBsAg组(n=59)和高HBsAg组(n=80).分析两组患者基线和随访终点各指标变化情况,比较两组患者随访结束时HBsAg下降≥0.5 log10IU/ml率、HBV DNA阴转率、ALT持续正常率以及肝脏硬度测定值(LSM)持续正常率.计量资料组间比较采用t检验或非参数Mann-Whitney U检验、Wilcoxon符号秩和检验;计数资料组间比较采用x2检验或Fisher确切概率法.结果 两组患者基线年龄、性别、HBsAg差异有统计学意义,乙型肝炎家族史、随访时间、抗-HBe、抗-HBc、HBV DNA、ALT、天冬氨酸转氨酶(AST)、白蛋白(Alb)、LSM差异无统计学意义.低HBsAg组患者HBsAg、抗-HBc、ALT水平随访前后差异有统计学意义,抗-HBe、HBV DNA、AST、Alb、LSM水平差异无统计学意义;高HBsAg组患者HBsAg、抗-HBc随访前后差异有统计学意义,抗-HBe、HBV DNA、ALT、AST、Alb、LSM差异无统计学意义.66例患者随访过程中行肝组织活检,27.27%患者肝组织存在中度损伤.低HBsAg组45.76%患者随访终点HBsAg下降≥0.5 log10IU/ml,10.17%患者HBV DNA阴转,88.14%患者ALT持续正常,96.61%患者LSM持续正常;高HBsAg组3.75%患者HBsAg下降≥0.5 log10IU/ml,无患者出现HBV DNA阴转,90.00%患者ALT持续正常,98.75%患者LSM持续正常.两组患者随访结束时HBsAg下降率(45.76%与3.75%,x2=32.975,P<0.001)、HBV DNA 阴转率(10.17%与0,x2=6.219,P=0.013)差异存在统计学意义,ALT和LSM持续正常率的差异无统计学意义.结论 绝大多数低病毒载量HBeAg阴性的不确定期慢性HBV感染者长期处于持续低病毒血症,部分患者肝组织存在损伤,可能进展为肝硬化、肝癌,只要其HBV DNA阳性,均应启动抗病毒治疗.
Analysis of the clinical characteristics of HBeAg-negative chronic HBV infection in indeterminate phase with a low viral load
Objective To analyze the clinical characteristics of HBeAg-negative chronic hepatitis B virus(HBV)infection in indeterminate phase with a low viral load.Methods One hundred and thirty-nine cases with persistent normal alanine aminotransferase(ALT)and HBeAg-negative chronic HBV infection with low viral load who visited the Department of Infectious Diseases of the Affiliated Hospital of Yan'an University from September 2013 to July 2021 were retrospectively collected.Patients were divided into low hepatitis B surface antigen(HBsAg)group(n=59)and high HBsAg group(n=80)according to the baseline hepatitis B surface antigen(HBsAg)level.The changes of various indicators at baseline and follow-up endpoints were analyzed between the two groups.The rate of HBsAg decrease ≥0.5 log10IU/ml,HBV DNA negative conversion rate,ALT persistently normal rate,and liver stiffness measurement(LSM)persistently normal rate at the end of the follow-up were compared.The t-test,or non-parametric Mann-Whitney U test,and Wilcoxon signed rank test were used for comparison of continuous data between the two groups.The x2 test,or Fisher's exact probability method,was used for comparing count data between the two groups.Results There were statistically significant differences in age,gender,and HBsAg at baseline,but there was no statistically significant difference in terms of family history of hepatitis B,follow-up time,anti-HBe,anti-HBc,HBV DNA,ALT,aspartate aminotransferase(AST),albumin(Alb),and LSM between the two groups.There were statistically significant differences in HBsAg,anti-HBc,and ALT levels before and after follow-up in the low HBsAg group,but no statistically significant differences in anti-HBe,HBV DNA,AST,Alb,and LSM levels.There were statistically significant differences in HBsAg and anti-HBc before and after follow-up in the high HBsAg group,but no statistically significant differences in anti-HBe,HBV DNA,ALT,AST,Alb,and LSM.A liver biopsy was performed in 66 patients during follow-up,and 27.27%of the patients had moderate liver damage.In the low HBsAg group,45.76%of patients had a HBsAg decrease rate of ≥0.5 log10IU/ml,10.17%of patients had HBV DNA negative conversion,88.14%of patients had a persistently normal ALT,and 96.61%of patients had a persistently normal LSM at the end of follow-up.In the high HBsAg group,3.75%of patients had a HBsAg decrease of ≥0.5 log10IU/ml,no patient had a HBV DNA negative conversion,90%of patients had a persistently normal ALT,and 98.75%of patients had a persistently normal LSM.There were statistically significant differences in the HBsAg decrease rate(45.76%vs.3.75%,x2=32.975,P<0.001)and HBV DNA negative conversion rate(10.17%vs.0,x2=6.219,P=0.013)between the two groups at the end of follow-up,but there were no statistically significant differences in the persistently normal ALT and LSM rates.Conclusion The vast majority of patients with HBeAg-negative chronic HBV infection in the indeterminate phase with low viral load had persistent hypoviremia over the long term.Some patients have liver tissue damage and may progress to cirrhosis and liver cancer as a result of HBV DNA positivity,so antiviral treatment should be initiated in all.

Chronic hepatitis BLow viral loadIndeterminate phaseClinical characteristics

周路路、白萧萧、东冰、辛杰晶、徐光华、刘娜

展开 >

延安大学附属医院感染病科延安市重点实验室,延安 716000

榆林市第一医院感染科,榆林 719000

慢性乙型肝炎 低病毒载量 不确定期 临床特征

2024

中华肝脏病杂志
中华医学会

中华肝脏病杂志

CSTPCD北大核心
影响因子:1.625
ISSN:1007-3418
年,卷(期):2024.32(11)